watch for metabolic acidosis in patients taking Topamax (topiramate)
March 2004
There's a new warning to watch for metabolic acidosis in patients taking Topamax (topiramate).
This is even more important now that Topamax will be used for so many conditions other than epilepsy. It's gaining acceptance for tremors and weight loss. And Topamax will be approved for migraine prophylaxis.
Topamax inhibits carbonic anhydrase. This increases renal excretion of bicarbonate.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote